The Trauma Collaborative Care Study (TCCS).

J Orthop Trauma

*Department of Physical Medicine and Rehabilitation, Johns Hopkins School of Medicine, Baltimore, MD; †R Adams Cowley Shock Trauma Center, Department of Orthopaedics, University of Maryland School of Medicine, Baltimore, MD; ‡Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; §Inova Fairfax Medical Campus, Department of Orthopaedic Surgery, Orthopaedic Trauma, Fairfax, VA; ‖Department of Orthopaedic Surgery and Department of Physical Medicine and Rehabilitation, Vanderbilt University Medical Center, Nashville, TN; ¶The CORE Institute, University of Arizona Medical College - Phoenix, Banner University Medical Center, Phoenix, AZ; **Carolinas Medical Center, Department of Orthopaedic Surgery, Charlotte, NC; and ††Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.

Published: April 2017

AI Article Synopsis

  • The Trauma Collaborative Care (TCC) program aims to enhance trauma patient care by integrating early emotional distress screening and psychological support.
  • The article outlines a multicenter study comparing outcomes of patients treated at six TCC intervention sites versus six control sites that follow standard care practices.
  • It is hypothesized that patients receiving the TCC program will exhibit improved recovery, showing lower rates of poor function, depression, and posttraumatic stress disorder compared to those receiving standard treatment alone.

Article Abstract

Previous research suggests that the care provided to trauma patients could be improved by including early screening and management of emotional distress and psychological comorbidity. The Trauma Collaborative Care (TCC) program, which is based on the principles of well-established models of collaborative care, was designed to address this gap in trauma center care. This article describes the TCC program and the design of a multicenter study to evaluate its effectiveness for improving patient outcomes after major, high-energy orthopaedic trauma at level 1 trauma centers. The TCC program was evaluated by comparing outcomes of patients treated at 6 intervention sites (n = 481) with 6 trauma centers where care was delivered as usual (control sites, n = 419). Compared with standard treatment alone, it is hypothesized that access to the TCC program plus standard treatment will result in lower rates of poor patient-reported function, depression, and posttraumatic stress disorder.

Download full-text PDF

Source
http://dx.doi.org/10.1097/BOT.0000000000000792DOI Listing

Publication Analysis

Top Keywords

tcc program
16
collaborative care
12
trauma collaborative
8
trauma centers
8
standard treatment
8
trauma
7
care
6
care study
4
study tccs
4
tccs previous
4

Similar Publications

Manufactured Chemicals and Children's Health - The Need for New Law.

N Engl J Med

January 2025

From Boston College Law School, Chestnut Hill, MA (D.A.W.); the University of Maryland at College Park, College Park (M.C.); Washington, DC (D.A.A.); the Global Observatory on Planetary Health, Boston College, Chestnut Hill, MA (C.B., T.C.C., C.G., K.S., E.M.W., A.Y., P.J.L.); the University of Louisville, Louisville, KY (A.B., T.R.S., J.C.S.); the Nicholas School of the Environment, Duke University, Durham, NC (L.S.B.); the Bloomberg School of Public Health, Johns Hopkins University, Baltimore (T.A.B.); the Zuckerberg College of Health Sciences, University of Massachusetts at Lowell, Lowell (K.G., J.A.T.); the United Nations Environment Program, Nairobi (P.K.); the Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy (D.M.); the University of Massachusetts at Amherst, Amherst (Y.P.); the Centre Scientifique de Monaco, Monaco (H.R., P.J.L.); the Innovation Lab, Client Earth, London (A.R.); the Barcelona Institute for Global Health, Barcelona (K.S.); the University of Texas School of Law, Austin (W.W.); the Technology and Society Laboratory, Empa-Swiss Federal Laboratories for Materials Science and Technology, St. Gallen, Switzerland (Z.W.); and the Environmental Research and Translation for Health Center and the Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, San Francisco (T.J.W.).

View Article and Find Full Text PDF

Remotely Sequential Activation of Biofunctional MXenes for Spatiotemporally Controlled Photothermal Cancer Therapy Integrated with Multimodal Imaging.

Small

December 2024

State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, 210023, China.

Article Synopsis
  • The study introduces TCC@M, a nanoprobe that combines CRISPR-Cas9 gene editing and photothermal therapy to treat cancer more effectively by targeting specific cells at the right time.
  • TCC@M is activated by near-infrared light, allowing for controlled release of the Cas9 protein, which specifically alters a gene linked to cancer cell survival, making the cells more susceptible to increased temperatures.
  • The research demonstrates that this innovative method not only improves cancer treatment precision but also allows for real-time monitoring through various imaging techniques.
View Article and Find Full Text PDF

Background: Hashimoto's thyroiditis (HT) is the most common autoimmune thyroid disease (AITD), which is distinguished by high thyroid peroxidase antibody (TPOAb) or thyroglobulin antibody (TgAb). The differentiation of CD4T cell subsets in patients with HT is imbalanced, with Treg cells decreased and Th17 cells abnormally activated. Fatty acid oxidation supports the differentiation of Th17 cells and induces inflammation, but the specific mechanism is still unknown.

View Article and Find Full Text PDF
Article Synopsis
  • * Cryptotanshinone (CTS), derived from the medicinal herb Danshen, has shown cytotoxic effects on bladder cancer cells while not harming normal cells, primarily through inducing apoptosis.
  • * CTS works by inhibiting the JAK2/STAT3/BCL-2 signaling pathway, suggesting its potential as a therapeutic agent for treating bladder cancer.
View Article and Find Full Text PDF

The changing needs of our nation's military veterans call for a change in the healthcare system delivery models providing their primary sources of care. The VA Healthcare System has incorporated a whole health movement emphasizing individualized approaches to healthcare by encouraging complementary and integrative programs. Wheelchair/Adaptive Tai Chi Chuan (W/A/TCC) is such program offering a transformative opportunity to programmatically enhance veteran healthcare services by enhancing the training of VA healthcare providers.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!